EP08.02-139 A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs

Authors :: S. Lu
Y. Zhang
G. Zhang
J. Zhou
S. Cang
Y. Cheng
G. Wu
P. Cao
D. Lv
H. Jian
C. Chen
X. Jin
P. Tian
K. Wang
G. Jiang
G. Chen
Q. Chen
H. Zhao
C. Ding
R. Guo
G. Sun
B. Wang
L. Jiang
Z. Liu
J. Fang
J. Yang
W. Zhuang
Y. Liu
J. Zhang
Y. Pan
J. Chen
Q. Yu
M. Zhao
J. Cui
D. Li
T. Yi
Z. Yu
Y. Yang
X. Zhi
Y. Huang
R. Wu
L. Chen
A. Zang
L. Cao
Q. Li
X. Li
Y. Song
D. Wang
S. Zhang
Source :: Journal of Thoracic Oncology. 17:S469
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools